QRG Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$175M Buy
146,305
+12,755
+10% +$13M 1.45% 11
2026
Q1
$123M Buy
133,550
+20,139
+18% +$20.4M 1.27% 11
2025
Q4
$122M Buy
113,411
+9,963
+10% +$9.53M 1.36% 11
2025
Q3
$78.9M Sell
103,448
-25,979
-20% -$19.3M 0.96% 14
2025
Q2
$101M Buy
129,427
+3,202
+3% +$2.49M 0.88% 15
2025
Q1
$104M Buy
126,225
+7,374
+6% +$6.14M 1.08% 12
2024
Q4
$91.8M Sell
118,851
-2,311
-2% -$1.91M 0.94% 13
2024
Q3
$107M Buy
121,162
+1,980
+2% +$1.78M 1.16% 12
2024
Q2
$108M Buy
119,182
+4,767
+4% +$3.81M 1.28% 10
2024
Q1
$89M Buy
114,415
+348
+0.3% +$248K 1.13% 10
2023
Q4
$66.5M Buy
114,067
+8,272
+8% +$4.83M 0.99% 14
2023
Q3
$56.8M Buy
+105,795
New +$54.5M 0.99% 16

Other funds holding LLY

QRG Capital Management's LLY Position: Q2 2026 in Review

QRG Capital Management increased its Eli Lilly (LLY) stake by 9.6% in Q2 2026, buying an estimated $13M and bringing the position to 146,305 shares worth $175M. The position accounts for 1.45% of the portfolio, ranked #11.

QRG Capital Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 809 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • QRG Capital Management held 146,305 shares of Eli Lilly worth $175M as of Q2 2026.
  • QRG Capital Management bought 12,755 Eli Lilly shares in Q2 2026, an estimated $13M.
  • Eli Lilly made up 1.45% of QRG Capital Management's portfolio in Q2 2026, its #11 holding.
  • QRG Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 809 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on QRG Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.